NeueHealth, Inc.
NEUE
$6.51
$0.01830.28%
NYSE
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 29.96% | 32.83% | 5.31% | 18.90% | 28.83% |
| Total Other Revenue | -22.31% | -27.01% | -27.25% | -22.91% | -34.78% |
| Total Revenue | -7.48% | -11.96% | -20.57% | -13.54% | -24.16% |
| Cost of Revenue | -17.60% | -18.28% | -30.19% | -19.32% | -27.52% |
| Gross Profit | 29.73% | 13.84% | 70.48% | 16.94% | -8.54% |
| SG&A Expenses | -36.34% | -27.09% | 0.13% | -32.52% | 0.27% |
| Depreciation & Amortization | -10.63% | -21.99% | -10.51% | -14.89% | -14.84% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -22.73% | -20.53% | -23.73% | -23.11% | -21.24% |
| Operating Income | 154.55% | 111.52% | 44.10% | 69.09% | -18.12% |
| Income Before Tax | 117.28% | -120.89% | 29.53% | 95.19% | -21.06% |
| Income Tax Expenses | 88.77% | -83.26% | -142.26% | 182.51% | 79.04% |
| Earnings from Continuing Operations | 117.42% | -125.28% | 32.39% | 94.57% | -23.88% |
| Earnings from Discontinued Operations | 54.52% | 4.61% | 111.31% | 78.84% | 67.61% |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -812.77% | 92.41% | -102.27% | 80.35% | 96.15% |
| Net Income | 82.85% | 26.23% | 98.82% | 90.94% | 48.04% |
| EBIT | 154.55% | 111.52% | 44.10% | 69.09% | -18.12% |
| EBITDA | 180.38% | 133.55% | 38.69% | 73.38% | -26.93% |
| EPS Basic | 69.74% | 17.77% | 93.64% | 89.50% | 44.90% |
| Normalized Basic EPS | 78.85% | 93.93% | -114.91% | 77.36% | 59.32% |
| EPS Diluted | 69.74% | 17.77% | 93.64% | 89.50% | 44.90% |
| Normalized Diluted EPS | 78.85% | 93.93% | -114.91% | 77.36% | 59.32% |
| Average Basic Shares Outstanding | 8.78% | 6.08% | 3.42% | 3.82% | 3.65% |
| Average Diluted Shares Outstanding | 8.78% | 6.08% | 3.42% | 3.82% | 3.65% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |